PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy.

Bonomi 2023 · Bonomi Marcelo, Blakaj Dukagjin M, Kabarriti Rafi, et al. · International journal of radiation oncology, biology, physics · 2023